Institut Pasteur Korea

A Glimpse Into the Central Nervous System Wins the 13th Annual Nikon Small World in Motion Competition

Retrieved on: 
Tuesday, September 26, 2023

MELVILLE, N.Y., Sept. 26, 2023 /PRNewswire/ -- Nikon Instruments Inc. today unveiled the winners of the 13th annual Nikon Small World in Motion Video Competition. This year's first place prize was awarded to Dr. Alexandre Dumoulin for his 48-hour time-lapse video of developing neurons connecting to the opposite side of the central nervous system in a chick embryo. Developed at the University of Zurich, Dumoulin's video plays a significant role in understanding the potential deviations in neurodevelopmental disorders that occur in the central nervous system, such as autism spectrum disorder and schizophrenia.

Key Points: 
  • With the potential to better understand neurodevelopmental disorders, this year's Nikon Small World in Motion winning video has universal applications
    MELVILLE, N.Y., Sept. 26, 2023 /PRNewswire/ -- Nikon Instruments Inc. today unveiled the winners of the 13th annual Nikon Small World in Motion Video Competition .
  • They are connected with long extensions known as axons and these axons traverse the nervous system before eventually forming synapses.
  • Dumoulin's video showcases these lengthy axons projecting across the midline, which serves as a boundary between the two hemispheres of the central nervous system.
  • He went on to say, "The nervous system is an immensely complex and intricate system composed of a myriad of units that are connected to one another.

Sensorion Reports 2023 First Half Results

Retrieved on: 
Wednesday, September 20, 2023

In the first half of 2023, Sensorion achieved a major development milestone by completing the preclinical package, and successfully producing the GMP dual AAV OTOF-GT batches at 200L clinical scale.

Key Points: 
  • In the first half of 2023, Sensorion achieved a major development milestone by completing the preclinical package, and successfully producing the GMP dual AAV OTOF-GT batches at 200L clinical scale.
  • In April 2023, Sensorion announced the candidate selection for GJB2-GT during its R&D Day focusing on gene therapy.
  • The first patient was enrolled in December 2022 and Sensorion anticipates the publication of the preliminary results in H2 2023.
  • The annual accounts on June 30, 2023, drawn up according to IFRS standards and approved by the Board of Directors on September 18, 2023.

Ipsen announces change in R&D leadership: Howard Mayer to retire, succeeded by Christelle Huguet

Retrieved on: 
Friday, September 1, 2023

She will succeed Howard Mayer, EVP and Head of R&D, who will leave Ipsen on September 22, following his decision to retire.

Key Points: 
  • She will succeed Howard Mayer, EVP and Head of R&D, who will leave Ipsen on September 22, following his decision to retire.
  • Christelle Huguet will serve on the Executive Leadership Team (ELT), reporting directly to Ipsen’s Chief Executive Officer, David Loew and immediately succeeding Howard upon his departure.
  • “I am very pleased that Christelle will join Ipsen’s Executive Leadership team as we continue to successfully deliver on our strategic roadmap.
  • “I know firsthand that our R&D organization is committed to Ipsen’s ambitious innovation agenda,” said Christelle Huguet.

Lady Mireille and Sir Dennis Gillings Global Public Health Fellowships advance the next generation of leaders

Retrieved on: 
Tuesday, July 25, 2023

NEW YORK, and PARIS, July 25, 2023 /PRNewswire/ -- The Pasteur Foundation US and the Institut Pasteur are pleased to announce that the 2023 cohort of Lady Mireille and Sir Dennis Gillings Global Public Health Fellowships have been conferred.

Key Points: 
  • NEW YORK, and PARIS, July 25, 2023 /PRNewswire/ -- The Pasteur Foundation US and the Institut Pasteur are pleased to announce that the 2023 cohort of Lady Mireille and Sir Dennis Gillings Global Public Health Fellowships have been conferred.
  • The fellowships, the vision of Lady Mireille Gillings, are curated by an unprecedented group of international partners made up of the University of Cambridge, the University of North Carolina Gillings School of Global Public Health and Concordia University, Montreal.
  • "Future leaders in public health must have skills across what I call the 3Ms: management, money and medicine," said Lady Mireille Gillings, "The fellowships are designed to build business acumen on top of scientific experience, which is critical for the next generation of global scientists."
  • "The Lady Mireille and Sir Dennis Gillings Global Public Health Fellowships are funded and supported by visionary leadership from Lady Mireille Gillings.

Lady Mireille and Sir Dennis Gillings Global Public Health Fellowships advance the next generation of leaders

Retrieved on: 
Tuesday, July 25, 2023

NEW YORK, and PARIS, July 25, 2023 /PRNewswire/ -- The Pasteur Foundation US and the Institut Pasteur are pleased to announce that the 2023 cohort of Lady Mireille and Sir Dennis Gillings Global Public Health Fellowships have been conferred.

Key Points: 
  • NEW YORK, and PARIS, July 25, 2023 /PRNewswire/ -- The Pasteur Foundation US and the Institut Pasteur are pleased to announce that the 2023 cohort of Lady Mireille and Sir Dennis Gillings Global Public Health Fellowships have been conferred.
  • The fellowships, the vision of Lady Mireille Gillings, are curated by an unprecedented group of international partners made up of the University of Cambridge, the University of North Carolina Gillings School of Global Public Health and Concordia University, Montreal.
  • "Future leaders in public health must have skills across what I call the 3Ms: management, money and medicine," said Lady Mireille Gillings, "The fellowships are designed to build business acumen on top of scientific experience, which is critical for the next generation of global scientists."
  • "The Lady Mireille and Sir Dennis Gillings Global Public Health Fellowships are funded and supported by visionary leadership from Lady Mireille Gillings.

27 to 29 June, Paris - World Leaders & Scientists to Discuss: Basic Research Can Pioneer New Approaches to Global Challenges

Retrieved on: 
Monday, June 26, 2023

PARIS, June 26, 2023 /PRNewswire/ -- "Fundamental Life Science Meets Climate, Environment, and Sustainability," invites world leaders and scientists to forge new partnerships and propose systems-level approaches to solve global challenges. The events contribute toward the U.N. International Year of Basic Sciences for Sustainable Development.

Key Points: 
  • PARIS, June 26, 2023 /PRNewswire/ -- "Fundamental Life Science Meets Climate, Environment, and Sustainability," invites world leaders and scientists to forge new partnerships and propose systems-level approaches to solve global challenges.
  • High-Level Summit, 27 June, at French Academy of Sciences:
    International Scientific Symposium, 28 & 29 June, at Auditorium André and Liliane Bettencourt:
    English speakers: Rachael Bishop, [email protected] , +33 (0)7 81 87 62 21.
  • The Human Frontier Science Program was established in 1989 to advance international research and training at the frontier of life sciences.
  • With its collaborative research grants and postdoctoral fellowships, the program has awarded more than 4,500 fellowships involving more than 7,500 scientists from around the world.

27 to 29 June, Paris - World Leaders & Scientists to Discuss: Basic Research Can Pioneer New Approaches to Global Challenges

Retrieved on: 
Monday, June 26, 2023

PARIS, June 26, 2023 /PRNewswire/ -- "Fundamental Life Science Meets Climate, Environment, and Sustainability," invites world leaders and scientists to forge new partnerships and propose systems-level approaches to solve global challenges. The events contribute toward the U.N. International Year of Basic Sciences for Sustainable Development.

Key Points: 
  • PARIS, June 26, 2023 /PRNewswire/ -- "Fundamental Life Science Meets Climate, Environment, and Sustainability," invites world leaders and scientists to forge new partnerships and propose systems-level approaches to solve global challenges.
  • High-Level Summit, 27 June, at French Academy of Sciences:
    International Scientific Symposium, 28 & 29 June, at Auditorium André and Liliane Bettencourt:
    English speakers: Rachael Bishop, [email protected] , +33 (0)7 81 87 62 21.
  • The Human Frontier Science Program was established in 1989 to advance international research and training at the frontier of life sciences.
  • With its collaborative research grants and postdoctoral fellowships, the program has awarded more than 4,500 fellowships involving more than 7,500 scientists from around the world.

DxVx appoints Yong Gu Lee as new CEO and Kevin Kwon as the new president

Retrieved on: 
Tuesday, May 16, 2023

SEOUL, South Korea, May 16, 2023 /PRNewswire/ -- DxVx announced on the 16th, the board of directors appointed Yong Gu Lee as the new CEO and Kevin Kwon, the former head of global business division at Hanmi Pharm.Co.,Ltd., as the new president. Drawing on the expertise of sales veterans who have more than 30 years of experience, the company plans to actively reorganize the global sales networks, launch new products and further enhance its capabilities to get global approvals for new drugs.

Key Points: 
  • SEOUL, South Korea, May 16, 2023 /PRNewswire/ -- DxVx announced on the 16th, the board of directors appointed Yong Gu Lee as the new CEO and Kevin Kwon, the former head of global business division at Hanmi Pharm.Co.,Ltd., as the new president.
  • The new CEO, Yong Gu Lee, graduated from Hanyang University.
  • Co., Ltd., managing director of the healthcare business division at Beijing Medi'Care Co., Ltd and vice president of the COREE Group.
  • New president Kevin Kwon will be appointed as a board director from a shareholders' meeting.

Biotia Launches GeoSeeq Watchtower System: A Global Genomics-Based Infectious Disease Monitoring Program

Retrieved on: 
Friday, May 12, 2023

NEW YORK, May 12, 2023 /PRNewswire-PRWeb/ -- Biotia, a health tech company based in New York City, announced today its launch of the GeoSeeq Watchtower System. Using genomics, the program provides support for 12 groups monitoring infectious disease hotspots to profile emerging infectious disease risks.

Key Points: 
  • Deployed across eight countries on four continents, the program will generate genomics data to predict infectious disease threats and optimize outbreak response.
  • NEW YORK, May 12, 2023 /PRNewswire-PRWeb/ -- Biotia , a health tech company based in New York City, announced today its launch of the GeoSeeq Watchtower System.
  • Using genomics, the program provides support for 12 groups monitoring infectious disease hotspots to profile emerging infectious disease risks.
  • The COVID-19 pandemic highlighted the fragility of global health, social systems and economies and revealed the need for a more robust global infectious disease-monitoring system.

Sensorion Announces Candidate Selection for GJB2 Gene Therapy Program

Retrieved on: 
Thursday, April 6, 2023

Géraldine Honnet, M.D., Chief Medical Officer of Sensorion, said: “We are very proud to have selected a candidate for our GJB2-GT program.

Key Points: 
  • Géraldine Honnet, M.D., Chief Medical Officer of Sensorion, said: “We are very proud to have selected a candidate for our GJB2-GT program.
  • “Sensorion believes gene therapy has the potential to transform lives and we are delighted to be moving this promising candidate forward towards clinical development.
  • Sensorion also plans to file a Clinical Trial Application for its OTOF-GT program, a dual-vector AAV gene therapy program for the treatment of children born with hearing loss caused by otoferlin deficiency this quarter.
  • Christine Petit
    GJB2-GT Program: Data to Drive Next Steps, Dr. Laurent Désiré
    GJB2-GT Program: Natural History Studies to Prepare Execution of Clinical Trials, Dr. Géraldine Honnet
    OTOF-GT Program: SENS-501, Sensorion’s Lead Gene Therapy Program, Dr. Laurent Désiré
    Enabling Reliable Gene Therapy Manufacturing and Analytical Control, Dr. Christine Le Bec